Free Trial

Elevai Labs Q3 2023 Earnings Report

Elevai Labs logo
$1.20 -0.02 (-1.24%)
As of 02:17 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Elevai Labs EPS Results

Actual EPS
-$16.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elevai Labs Revenue Results

Actual Revenue
$0.56 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elevai Labs Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Elevai Labs Earnings Headlines

Elevai Labs, Inc. (NASDAQ:ELAB) Short Interest Down 44.6% in February
Trump doesn’t give a damn
Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…
Analyzing Elevai Labs (NASDAQ:ELAB) and Inventiva (NASDAQ:IVA)
PMGC files to sell 969,386 shares of common stock for holders
See More Elevai Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elevai Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevai Labs and other key companies, straight to your email.

About Elevai Labs

Elevai Labs (NASDAQ:ELAB), a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

View Elevai Labs Profile

More Earnings Resources from MarketBeat